Cidara Therapeutics, Inc. (CDTX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 302K | 973K | 17.58M | 9.22M | 5.09M | 26.11M | 10.22M | 40.74M | 6.22M | 7.11M | 7.22M | 7.08M | 32.86M | 2.41M | 3.73M |
| Revenue Growth % | - | -100% | -100% | -100% | -100% | -94.07% | -96.27% | 72.06% | -77.38% | -18.11% | 267.24% | 41.44% | 475.81% | -81.09% | 195.22% | 93.75% | 192.88% | 868.84% | -4.82% | 105.45% |
| Cost of Goods Sold | 45M | 0 | 0 | 0 | 0 | 0 | 5.92M | 1.14M | 10.39M | 0 | 0 | 0 | 0 | 15.26M | 0 | 19.01M | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | 608.32% | 6.46% | 112.68% | - | - | - | - | 245.42% | - | 263.16% | - | - | - | - |
| Gross Profit | -45M | 0 | 0 | 0 | 0 | 302K | -4.95M | 16.45M | -1.17M | 5.09M | 26.11M | 10.22M | 40.74M | -9.04M | 7.11M | -11.79M | 7.08M | 32.86M | 2.41M | 3.73M |
| Gross Margin % | - | - | - | - | - | 100% | -508.32% | 93.54% | -12.68% | 100% | 100% | 100% | 100% | -145.42% | 100% | -163.16% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | - | -100% | 100% | -100% | 100% | -94.07% | -118.95% | 60.95% | -102.87% | 156.31% | 267.24% | 186.69% | 475.81% | -127.51% | 195.22% | -416.12% | 192.88% | 868.84% | -4.82% | 105.45% |
| Operating Expenses | 43.63M | 27.38M | 25.27M | 54.18M | 17.39M | 96.29M | 3.6M | 22.52M | 3.3M | 11.84M | 23.33M | 23.49M | 25.82M | 4.07M | 25.37M | 4.98M | 25.11M | 22.09M | 20.63M | 25.28M |
| OpEx % of Revenue | - | - | - | - | - | 31882.78% | 369.58% | 128.08% | 35.79% | 232.57% | 89.35% | 229.83% | 63.37% | 65.54% | 356.87% | 68.95% | 354.89% | 67.22% | 856.73% | 677.85% |
| Selling, General & Admin | 8.1M | 6.5M | 6.18M | 7.31M | 4.96M | 4.75M | 3.6M | 7.17M | 3.3M | 3.18M | 4.46M | 3.43M | 5.78M | 4.07M | 5.2M | 4.98M | 4.61M | 4.37M | 4.78M | 4.15M |
| SG&A % of Revenue | - | - | - | - | - | 1571.52% | 369.58% | 40.77% | 35.79% | 62.5% | 17.07% | 33.55% | 14.19% | 65.54% | 73.2% | 68.95% | 65.11% | 13.3% | 198.55% | 111.24% |
| Research & Development | 35.53M | 24.82M | 24.6M | 46.87M | 12.43M | 6.66M | 5.92M | 15.35M | 10.39M | 8.66M | 18.87M | 20.06M | 20.04M | 15.26M | 20.17M | 19.01M | 20.5M | 17.72M | 15.85M | 21.13M |
| R&D % of Revenue | - | - | - | - | - | 2204.3% | 608.32% | 87.31% | 112.68% | 170.08% | 72.28% | 196.28% | 49.19% | 245.42% | 283.67% | 263.16% | 289.78% | 53.92% | 658.18% | 566.61% |
| Other Operating Expenses | 0 | -1000K | -1000K | 0 | 0 | 1000K | -1000K | 0 | -1000K | 0 | 0 | 0 | 0 | -1000K | 0 | -1000K | 0 | 0 | 0 | 0 |
| Operating Income | -88.63M | -27.38M | -25.27M | -54.18M | -17.39M | -95.98M | -8.54M | -6.07M | -4.47M | -6.75M | 2.78M | -13.27M | 14.92M | -13.11M | -18.26M | -16.77M | -18.04M | 10.77M | -18.22M | -21.55M |
| Operating Margin % | - | - | - | - | - | -31782.78% | -877.9% | -34.54% | -48.48% | -132.57% | 10.65% | -129.83% | 36.63% | -210.96% | -256.87% | -232.11% | -254.89% | 32.78% | -756.73% | -577.85% |
| Operating Income Growth % | -409.53% | 71.47% | -195.82% | -792.03% | -289.3% | -1322.41% | -407.16% | 54.22% | -129.94% | 48.54% | 115.23% | 20.89% | 182.74% | -221.72% | -0.21% | 22.17% | -2.89% | 159.16% | -25.14% | -53.04% |
| EBITDA | -88.6M | -27.36M | -25.22M | -54.12M | -17.33M | -95.93M | -8.51M | -6.04M | -4.45M | -6.72M | 2.81M | -12.95M | 14.96M | -13.07M | -17.96M | -16.73M | -17.74M | 11.04M | -17.96M | -21.5M |
| EBITDA Margin % | - | - | - | - | - | -31763.91% | -874.2% | -34.32% | -48.24% | -132.08% | 10.77% | -126.74% | 36.72% | -210.34% | -252.69% | -231.6% | -250.76% | 33.59% | -745.81% | -576.64% |
| EBITDA Growth % | -411.16% | 71.48% | -196.5% | -796.82% | -289.86% | -1326.85% | -402.38% | 53.4% | -129.72% | 48.58% | 115.66% | 22.6% | 184.31% | -218.44% | -0.03% | 22.18% | -1.6% | 160.82% | -23.84% | -53.49% |
| D&A (Non-Cash Add-back) | 28K | 27K | 49K | 59K | 61K | 57K | 36K | 39K | 22K | 25K | 32K | 315K | 37K | 38K | 297K | 37K | 292K | 266K | 263K | 45K |
| EBIT | -83.23M | -27.38M | -25.27M | -54.18M | -17.39M | -11.1M | -8.54M | -6.07M | -4.47M | -6.75M | 2.78M | -13.27M | 14.92M | -13.11M | -18.26M | -16.77M | -18.04M | 10.77M | -18.22M | -21.55M |
| Net Interest Income | 0 | 1.67M | 1.9M | 1.81M | 1.86M | 1.77M | 365K | 527K | 613K | 623K | 232K | 162K | 55K | -6K | -20K | -33K | -47K | -62K | -70K | -86K |
| Interest Income | 0 | 1.67M | 1.9M | 1.81M | 1.86M | 1.77M | 365K | 527K | 613K | 623K | 232K | 162K | 55K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6K | 20K | 33K | 47K | 62K | 70K | 86K |
| Other Income/Expense | 5.39M | 1.67M | 1.79M | 1.81M | 1.86M | 1.77M | 365K | 527K | 677K | 623K | 232K | 162K | 55K | -6K | -20K | -33K | -47K | -62K | -70K | -86K |
| Pretax Income | -83.23M | -25.72M | -23.48M | -52.37M | -15.54M | -94.21M | -8.18M | -5.55M | -3.79M | -6.13M | 3.01M | -13.11M | 14.98M | -13.12M | -18.28M | -16.8M | -18.08M | 10.71M | -18.29M | -21.63M |
| Pretax Margin % | - | - | - | - | - | -31195.36% | -840.39% | -31.55% | -41.13% | -120.33% | 11.54% | -128.24% | 36.76% | -211.05% | -257.15% | -232.57% | -255.55% | 32.59% | -759.63% | -580.16% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 64K | 32K | 40K | 0 | 272K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -1.15% | -0.84% | -0.65% | 0% | -2.08% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -83.23M | -25.72M | -23.48M | -52.31M | -15.98M | -91.21M | -10.33M | -5.61M | -9.11M | -13.62M | 3.01M | -13.38M | 14.98M | -13.12M | -18.28M | -16.8M | -18.08M | 10.71M | -18.29M | -21.63M |
| Net Margin % | - | - | - | - | - | -30201.66% | -1061.25% | -31.91% | -98.81% | -267.66% | 11.54% | -130.9% | 36.76% | -211.05% | -257.15% | -232.57% | -255.55% | 32.59% | -759.63% | -580.16% |
| Net Income Growth % | -420.69% | 71.8% | -127.39% | -832.22% | -75.52% | -569.47% | -442.71% | 58.05% | -160.8% | -3.85% | 116.48% | 20.39% | 182.83% | -222.48% | 0.06% | 22.33% | -2.56% | 158.51% | -25.81% | -54.28% |
| Net Income (Continuing) | -83.23M | -25.72M | -23.48M | -52.37M | -15.54M | -94.21M | -8.18M | -5.61M | -3.82M | -6.17M | 3.01M | -13.38M | 14.98M | -13.12M | -18.28M | -16.8M | -18.08M | 10.71M | -18.29M | -21.63M |
| Discontinued Operations | 0 | 0 | 0 | 62K | -450K | 1000K | -1000K | 0 | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -3.10 | -1.65 | -1.66 | -5.37 | -2.38 | -19.59 | -2.28 | -1.24 | -1.81 | -2.74 | 0.60 | -3.72 | 3.38 | -3.80 | -5.37 | -5.21 | -7.30 | 3.61 | -7.79 | -9.80 |
| EPS Growth % | -30.25% | 91.58% | 27.19% | -333.06% | -31.49% | -614.96% | -480% | 66.67% | -153.55% | 27.89% | 111.17% | 28.6% | 146.3% | -205.26% | 31.07% | 46.84% | 10.54% | 140.38% | -1.43% | -16.25% |
| EPS (Basic) | -3.10 | -1.65 | -1.66 | -5.37 | -2.38 | -19.59 | -2.28 | -1.25 | -1.81 | -2.80 | 0.77 | -3.72 | 3.39 | -4.98 | -5.41 | -5.22 | -7.40 | 3.62 | -8.72 | -9.80 |
| Diluted Shares Outstanding | 15.55M | 15.55M | 14.18M | 9.73M | 6.53M | 4.56M | 4.54M | 4.53M | 4.51M | 4.51M | 5.06M | 3.59M | 4.43M | 3.46M | 3.41M | 3.22M | 2.48M | 2.97M | 2.35M | 2.21M |
| Basic Shares Outstanding | 15.55M | 15.55M | 14.18M | 9.73M | 6.53M | 4.56M | 4.54M | 4.49M | 4.51M | 4.41M | 3.93M | 3.59M | 3.52M | 2.63M | 3.39M | 3.22M | 2.44M | 2.44M | 2.1M | 2.21M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |